According to the latest report by IMARC Group, titled “Botulinum Toxin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market exhibited moderate growth during 2015-2020. Botulinum toxin refers to a neurotoxin manufactured by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod that is commonly found in soil, plants, water, the intestinal tracts of several animals, etc. Botulinum toxin plays a significant role in the management of various medical conditions, such as strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, spastic movement disorders, etc. It is also utilized for numerous cosmetic purposes, including to temporarily reduce frown lines, creases, and wrinkles on the face, chin, neck, chest, etc.

Request Free Report Sample: https://www.imarcgroup.com/botulinum-toxin-market/requestsample

The increasing product utilization in the treatment of numerous dermatological conditions, such as abnormal gland activity and overactive smooth muscles, is primarily driving the botulinum toxin market across the globe. Additionally, the growing beauty consciousness among individuals and their willingness to undergo reconstructive and cosmetic surgeries are also propelling the market growth. Apart from this, the inflating levels of disposable incomes and urbanization, coupled with the emerging trend of cosmetic tourism, are acting as significant growth-inducing factors. Moreover, the expanding geriatric population is further catalyzing the market growth since the skin becomes more susceptible to sagging and wrinkles with age. In addition to this, various technological innovations, such as the development of new potent toxins to enhance the effectiveness of antigenic dose, are projected to bolster the botulinum toxin market in the coming years. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.

Checkout Now: https://www.imarcgroup.com/checkout?id=4453&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

  • AbbVie Inc.
  • Eisai Co. Ltd
  • Evolus Inc
  • Galderma SA
  • HUGEL Inc.
  • Ipsen Group
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Metabiologics Inc.
  • Revance Therapeutics Inc.

Key Highlights of the Market Segmentation:

Breakup by Type:

  • Toxin Type A
  • Toxin Type B

Breakup by Application:

  • Therapeutics
  • Aesthetics

Breakup by End User:

  • Hospitals and Clinics
  • Dermatology Clinics
  • Spas and Cosmetic Centres

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3m6JKND

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800